2024
Normal-Flow Low-Gradient Aortic Stenosis Comparing the U.S. and European Guidelines
Elkaryoni A, Huded C, Saad M, Altibi A, Chhatriwalla A, Abbott J, Arnold S. Normal-Flow Low-Gradient Aortic Stenosis Comparing the U.S. and European Guidelines. JACC Cardiovascular Imaging 2024, 17: 926-936. PMID: 38703172, DOI: 10.1016/j.jcmg.2024.03.005.Peer-Reviewed Original ResearchNormal-flow low-gradientSevere aortic stenosisModerate aortic stenosisAortic stenosisValve replacementEuropean Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelinesAmerican Heart Association/American College of Cardiology guidelinesLow-gradient aortic stenosisLow-gradient severe aortic stenosisAmerican Heart Association/American CollegeAortic valve replacementOutcomes of patientsSurgery guidelinesSurvival benefitCardiology guidelinesClinical entityStenosisDiagnostic algorithmEuropean guidelinesNatural historyPatientsEuropean AssociationPotential diagnostic algorithmsEuropean SocietyOutcomesImpact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy
Altibi A, Sapru A, Ghanem F, Zhao Y, Alani A, Cigarroa J, Nazer B, Song H, Masri A. Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy. International Journal Of Cardiology 2024, 400: 131790. PMID: 38242508, DOI: 10.1016/j.ijcard.2024.131790.Peer-Reviewed Original ResearchConceptsObstructive hypertrophic cardiomyopathyMitral valve replacementCoronary artery bypass graftingConcomitant surgical interventionIn-hospital mortalitySeptal myectomyAdverse in-hospital eventsIn-hospital eventsSurgical interventionMV repairValve replacementHypertrophic cardiomyopathyOutcomes of septal myectomyAssociated with increased in-hospital mortalityOutcomes of patientsAortic valve replacementIn-hospital adverse eventsAdverse clinical eventsIsolated SMArtery bypass graftingIn-hospital deathNational Readmission DatabaseSymptomatic patientsMedical therapyAdverse events
2019
Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis
Masri A, Altibi A, Erqou S, Zmaili M, Saleh A, Al-Adham R, Ayoub K, Baghal M, Alkukhun L, Barakat A, Jain S, Saba S, Adelstein E. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis. JACC Clinical Electrophysiology 2019, 5: 152-161. PMID: 30784684, PMCID: PMC6383782, DOI: 10.1016/j.jacep.2018.11.011.Peer-Reviewed Original ResearchConceptsRandomized controlled trialsWearable cardioverter-defibrillator therapyWearable cardioverter-defibrillatorVEST trialSudden cardiac deathDerSimonian and Laird methodCardiac deathMonths of follow-upPrevention of sudden cardiac deathA systematic reviewPrimary preventionOutcomes of patientsCardioverter-defibrillator therapyLaird methodObservational studyMeta-analysisGoogle ScholarIschemic cardiomyopathyMedical therapyFollow-upCardioverter-defibrillatorPreventionTherapyVestPersons